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Background: Caffeic acid phenethyl ester (CAPE), a component of propolis, is reported to possess anti-inflammatory,
anti-bacterial, anti-viral, and anti-tumor activities. Previously, our laboratory demonstrated the in vitro and in vivo
bioactivity of CAPE and addressed the role of p53 and the p38 mitogen-activated protein kinase (MAPK) pathway
in regulating CAPE-induced apoptosis in C6 glioma cells.
Results: C6 cancer cell lines were exposed to doses of CAPE; DNA fragmentation and MAPKs and NGF/P75NTR levels
were then determined. SMase activity and ceramide content measurement as well as western blotting analyses were
performed to clarify molecular changes. The present study showed that CAPE activated neutral sphingomyelinase
(N-SMase), which led to the ceramide-mediated activation of MAPKs, including extracellular signal-regulated kinase
(ERK), Jun N-terminus kinase (JNK), and p38 MAPK. In addition, CAPE increased the expression of nerve growth
factor (NGF) and p75 neurotrophin receptor (p75NTR). The addition of an N-SMase inhibitor, GW4869, established that
NGF/p75NTR was the downstream target of N-SMase/ceramide. Pretreatment with MAPK inhibitors demonstrated that
MEK/ERK and JNK acted upstream and downstream, respectively, of NGF/p75NTR. Additionally, CAPE-induced caspase 3
activation and poly [ADP-ribose] polymerase cleavage were reduced by pretreatment with MAPK inhibitors, a p75NTR
peptide antagonist, or GW4869.
Conclusions: Taken together, N-SMase activation played a pivotal role in CAPE-induced apoptosis by activation of the
p38 MAPK pathway and NGF/p75NTR may explain a new role of CAPE induced apoptosis in C6 glioma.
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Nerve growth factorBackground
Caffeic acid phenethyl ester (CAPE) is secondary prod-
ucts of propolis and thus possesses anti-oxidant, anti-
angiogenic, anti-viral, anti-inflammatory, and anti-metastatic
properties. CAPE also selectively represses the proliferation
of several types of carcinoma cells, but show almost no toxic
effects on normal peripheral blood cells or on normal
hepatocytes [1-6]. Studies of previous studies have* Correspondence: jth.lin@gmail.com; guscsi@gmail.com
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unless otherwise stated.revealed a broad spectrum of biological activities that
CAPE induced apoptosis in oral cancer cells and glioma
cells [7,8]. In in vitro and in vivo studies, CAPE inhibited
the proliferation of C6 glioma cells [9]. Further, CAPE
enhanced all-trans retinoic acid-induced differentiation in
human leukemia HL-60 cells [10]. The mitogen-activated
protein kinases (MAPKs) are a family of protein kinases
that comprise a diverse superfamily of phylogenetically
conserved serine/threonine kinases. There are three
classical MAP kinase families: c-Jun N-terminal kinases
(JNKs), Ras/extracellular signal-regulated kinase (ERK),
and p38 MAPK. Although it is previously showed that
activation of ERK1/2 leads to cell growth, ERK1/2 acti-
vation results in cell apoptosis under some conditionstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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signalling to various stress signals, including TNFα,
oxidative stress, and ultraviolet (UV) light. Their activa-
tion is most frequently associated with the induction of
apoptosis [13,14]. Our previous study showed that CAPE
caused p53-dependent apoptosis in C6 glioma cells
through the p38 MAPK signaling pathway [8]. In addition
to activating p38 MAPK in C6 glioma cells, CAPE in-
creased the phosphorylation of ERK and JNK, whose
involvement was previously unknown.
Nerve growth factor (NGF) regulates neurotrophic
actions on many neurons in rats [15]. NGF are involved a
surprising variety of neurons, glia, and nonneural cells by
a high-affinity receptor TrkA and a low-affinity receptor,
p75 neurotrophin receptor (p75NTR) [16]. TrkA and
p75NTR collaborate to essentially takes place upon the
binding to the cell surface as neurotrophins [17]. It is now
thought that p75NTR play a crucial role in the glioma
apoptotic pathway [18]. p75NTR cognate TNFα superfam-
ily receptors Fas and CD40 are expressed in tissues to
which these glioma cells commonly death [19].
Three mammalian isoforms of neutral sphingomyeli-
nase (N-SMase) have been cloned to date. N-SMase is
membrane-bound and Mg2+-dependent. Acidic sphingo-
myelinase (A-SMase) has three isoforms, an endosomal
lysosomal A-SMase, a secretory Zn2+-dependent A-SMase,
and a receptor-activated A-SMase [20]. A ceramide is
composed of sphingosine and a fatty acid that serves as
a proapoptotic molecule [21]. Ceramide has been in-
volved in a variety of physiological functions including
apoptosis, cell growth arrest, differentiation, cell migra-
tion and adhesion. Several studies have attempted to
define the roles of SMase and ceramide on induction of
NGF synthesis in primary astrocyte cultures, indicating
it may be crosstalk between ceramide and NGF receptor
(NGFR) signaling in the nervous cells [22]. Further,
N-SMase plays a role in chemotherapy-mediated cell
death. In the present study, we examined whether SMase/
ceramide induced up-regulation of NGF/p75NTR is medi-
ated by CAPE-induced apoptosis, and we clarified the
relationship between SMase/ceramide, NGF/p75NTR, and
the MAPK signaling pathway in C6 glioma cells.
Methods
Chemical reagents and antibodies
All culture materials were purchased from Invitrogen
(Carlsbad, CA). The Amplex Red Sphingomyelinase kit
was purchased from Sigma (St. Louis, MO, USA). Sodium
dodecyl sulfide (SDS), bis-acrylamide, ammonium persul-
fate, N,N,N’,N’-tetramethylethylenediamine (TEMED), and
nitrocellulose (NC) paper were from Bio-Rad (Hercules,
CA). Caffeic acid phenethyl ester, Triton X-100, Tris base,
β-actin antibody, non-hydroxy fatty acid ceramide, and
4’,6-diamidino-2-phenylindole (DAPI) were from Sigma(St. Louis, MO). GW4869, a specific inhibitor of N-SMase,
was also purchased from Sigma. Antibodies against NGF,
p75NTR, Trk, poly [ADP-ribose] polymerase (PARP),
and caspase-3 were from Santa Cruz Biotechnology
(Santa Cruz, CA). The p75 antagonist peptide YCDIKG-
KECY (the cysteine-cysteine bond that results in cyclization
is underlined), which is reportedly specific to p75NTR, was
synthesized by Protech Technology (Reno, NV) to a
minimum of 90% purity [23]. High-performance thin-
layer chromatography (HPTLC) silica gel 60 plates were
obtained from Merck (Whitehouse Station, NJ).
Cell culture
The rat C6 glioma cell line was originally derived from an
N-nitrosomethylurea-induced rat brain tumor [24]. Cells
were cultured in minimal essential medium supplemented
with 10% fetal calf serum and antibiotics (100 U/ml of
penicillin and 100 mg/ml of streptomycin) at 37°C in
a humidified atmosphere of 5% CO2 and 95% air. All
experiments were performed in plastic tissue culture
flasks and dishes or in microplates (Nunc, Naperville,
Denmark).
Assessment of cell viability
Cell viability was assessed with the MTT colorimetric
assay. The cells were seeded at 2 × 104 cells/ml and incu-
bated with various concentrations of CAPE (0, 5, 10, 25,
50, and 100 μM) for 24 and 48 h. The medium was
changed, and the cells were incubated with 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT; 0.5 mg/ml) for 4 hr. The viable cell number was
directly proportional to the production of formazan,
which was solubilized with isopropanol and measured
spectrophotometrically at 563 nm.
Analysis of DNA fragmentation
C6 glioma cells cultured in 100-mm dishes were resus-
pended in 200 ml of hypotonic lysis buffer (0.2% Triton
X-100, 1 mM ethylenediaminetetraacetic acid (EDTA),
10 mM Tris–HCl, pH 7.5) and incubated for 20 min at
4°C. After centrifugation for 5 min at 14,000 × g, the
supernatant was collected, incubated with RNase A
(400 mg/ml) for 30 min at 37°C, and digested with
proteinase K (200 mg/ml) for 30 min at 50°C. The frag-
mented DNA was then precipitated overnight at −20°C
in 50% isopropanol and 0.5 M NaCl and centrifuged for
10 min at 14,000 × g. The dried pellets were dissolved in
20 ml of ultra-pure water, and DNA was separated by
electrophoresis on a 1.8% agarose gel at 50 V for 1 h.
Preparation of total cell extracts and immunoblot analysis
Cells were plated on 10-cm2 dishes at a density of 1 × 106
cells/ml in the presence or absence of CAPE (50 μM) for
0–24 h and harvested. To prepare whole-cell extracts,
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(PBS) plus zinc ion (1 mM) and suspended in lysis
buffer (50 mM Tris, 5 mM EDTA, 150 mM NaCl, 1%
NP-40, 0.5% deoxycholic acid, 1 mM sodium ortho-
vanadate, 81 μg/ml aprotinin, 170 mg/ml leupeptin,
100 mg/ml phenylmethylsulfonyl fluoride (PMSF);
pH 7.5). Lysates were mixed for 30 min at 4°C and centri-
fuged at 10,000 × g for 10 min. The supernatants were
collected as whole-cell extracts. The protein content
was determined with Bio-Rad protein assay reagent
using bovine serum albumin as a standard. Western
blotting with enhanced chemiluminescence (ECL) detec-
tion was performed as follows. Total cell lysates with equal
protein content from control and CAPE-treated samples
was resolved on 8%–12% SDS-PAGE gels along with
a prestained protein molecular weight standard (Bio-Figure 1 Involvement of MAPK activation in CAPE-induced apoptosis
treated with or without CAPE (50 and 100 μM) for the indicated times. DNA w
photographed under ultraviolet light. (B) Effect of CAPE on the activation
for the indicated times. Following treatment, cells were harvested, and cell lys
anti-phospho-JNK, anti-phospho-p38, anti-ERK, anti-JNK, anti-p38, and ant
caspase 3 activation and PARP cleavage. C6 glioma cells were pretreated
extracts were assessed by western blot analysis using anti-PARP and anti-proc
quantified by densitometry. The data is representative of two independen
viability. The data are shown as the percentage of the control group. Data
*P < 0.05, compared with control.Rad). Proteins were then blotted onto NC membranes
(Sartorious) and reacted with primary antibodies (anti-
caspase-3, anti-PARP, anti-Trk, anti-NGF, anti-p75, anti-
ERKs, anti-JNKs, anti-p38 MAPK, anti-phosphoserine,
anti-phospho-ERKs (Thr183/Tyr185), anti-phospho-JNKs
(Thr183/Tyr185), and anti-phospho-p38 (Thr180/Tyr182),
and anti-phospho-Trk from Santa Cruz Biotechnology
(Santa Cruz, CA); anti-β-actin from Sigma as an internal
control). The secondary antibody was a peroxidase-
conjugated goat anti-mouse antibody. After antibody
binding, the bands were visualized using a commercial
ECL kit.
SMase activity assay
SMase activity was analyzed with an Amplex Red Sphin-
gomyelinase Assay Kit. Cells were washed with PBS and. (A) CAPE induced DNA fragmentation in C6 glioma cells. Cells were
as separated on a 1.8% agarose gel, stained with ethidium bromide, and
of MAPKs. Cells were cultured in medium containing CAPE (50 μM)
ates were prepared for western blot analysis using anti-phospho-ERK,
i-actin antibodies. (C) Effect of MAPK inhibitors on CAPE-induced
with MAPK inhibitors for 1 h and then treated with CAPE for 24 h. Cell
aspase 3 antibodies. The bands were visualized with an ECL reagent and
t experiments. (D) Effect of MAPK inhibitors on CAPE-induced C6 cells
are presented as the mean ± S.D. of three independent experiments.
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The cell pellet was resuspended, lysed in buffer contain-
ing 1% Triton X-100, 1 μg/ml aprotinin, 1 mM EDTA,
and 100 μg/ml PMSF for 60 min on ice, and then centri-
fuged at 17,000 × g for 10 min at 4°C to remove the nu-
clei. The protein concentration in the supernatant was
measured with the Bio-Rad Protein Assay. To analyze
the activity of N-SMase, the supernatant was diluted
with 1× reaction buffer containing 0.1 M Tris–HCl and
10 mM MgCl2, pH 7.4, and then inoculated into 96-well
plates (100 μl/well). The total amount of protein in each
well was 25 μg. The solution was added to 100 μl of
working solution (containing 8 U/ml alkaline phosphatase,
0.2 U/ml choline oxidase, 2 U/ml horseradish peroxidase,
and 0.5 mM sphingomyelin) and incubated for 45 min at
37°C. The H2O2 generated reacted with Amplex Red to
elicit fluorescent resorufin. The fluorescent intensity was
measured with a fluorescence multi-well reader (HTS
7000) immediately at excitation/emission wavelengths
of 571/585 nm. Acid sphingomyelinase (A-SMase) ac-
tivity was analyzed with a two-step assay. First, the
supernatant was diluted with 50 mM sodium acetateFigure 2 Effect of CAPE-induced NGF/p75NTR activation on apoptosis
TrkA, and NGF in C6 glioma cells. Cells were treated with CAPE (50 μM) for
anti-p75NTR, anti-TrkA, anti-NGF, and anti-actin antibodies. Bands were visua
caspase-3 and PARP expression by the anti-p75NTR antagonist peptide. C6 gl
for 1 h and then treated with CAPE (50 μM) for 24 h. Cell extracts were as
anti-actin antibodies. Bands were visualized with an ECL reagent and quan
experiments.(not 1× reaction buffer), and 100 μl of the diluted
supernatant was inoculated to each well of a 96-well
plate. To generate phosphorylcholine and ceramide,
10 μl of 5 mM sphingomyelin solution was added to
each well and then incubated for 1 h at 37°C. Working
solution (100 μl) containing 8 U/ml alkaline phosphat-
ase, 0.2 U/ml choline oxidase, and 2 U/ml horseradish
peroxidase was then added to each well and reacted
with phosphorylcholine for 45 min at 37°C. The H2O2
generated from the two-step procedure then reacted
with Amplex Red to elicit resorufin, which was mea-
sured with a fluorescence multi-well reader as de-
scribed above.
Quantitative measurement of ceramide content
Cells were harvested in lysis buffer containing 50 mM
Tris–HCl, pH 6.8, 10% glycerol, 2% SDS, and 5% β-
mercaptoethanol and vortexed for 1 hr at 4°C. The lipids
were extracted by the following procedure. In brief, 1 ml
of cell lysate was suspended with 1.25 ml of chloroform
and 2.5 ml of methanol, vortexed, and incubated over-
night at 4°C. After centrifugation for 5 min at 1700 × g,in C6 glioma cells. (A) Effect of CAPE on the expression of p75NTR,
the indicated times. Protein in the total cell lysate was detected with
lized with an ECL reagent and quantified. (B) Inhibition of CAPE-induced
ioma cells were pretreated with the anti-p75NTR inhibitor (25 and 50 μM)
sessed by western blot analysis with anti-procaspase-3, anti-PARP, and
tified by densitometry. The data is representative of two independent
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added to the supernatant. The tubes were then vortexed
and centrifuged for 5 min at 1700 × g. The organic lower
phase was transferred to a fresh tube and evaporated.
The lipids were dissolved into chloroform-methanol [2:1
(v/v)] and analyzed using an HPTLC silica gel 60 plate.
Dichloromethane-methanol-glacial acetic acid [100:2:5
(v/v)] was used to separate the lipid. Individual lipid
classes were visualized by dipping each plate into CuSO4
(3%)/H3PO4 (8%) for 30 sec. The plate was thenFigure 3 The relationship between MAPKs and NGF/p75NTR after tre
on CAPE-induced NGF and p75NTR expression. C6 glioma cells were pr
(SB20358, 10 μM), or MEK/ERK inhibitor (PD98059, 10 μM) for 1 h and th
by western blot analysis using anti-NGF, anti-p75NTR, and anti-actin an
MAPK activation. C6 glioma cells were pretreated with the anti-p75NTR
indicated times. Cells extracts were assessed by western blot analysis u
anti-p38, anti-ERK, anti-JNK, and anti-actin antibodies. Bands were visua
representative of two independent experiments. *, apparent reduction
activation. Whole cell lysates from CAPE-treated C6 cells by western blo
of p38 (Thr180/Tyr182) and anti-actin.incubated in an oven at 180°C for 10 min. The bands
were scanned and the data were evaluated with an LAS-
3000 imager (Fuji Photo Film Co., Ltd., Tokyo, Japan). In
addition to the three sample replicates, C2-ceramide was
added to each plate as the lipid standard.
Determining the effects of MAPK inhibitors, SMase
inhibitors, and a p75NTR antibody inhibitor
C6 glioma cells were pretreated with 50 μM PD98059,
5 μM SB203580, 10 μM SP600125, 10 or 20 μM GW4869,atment with CAPE in C6 glioma cells. (A) Effect of MAPK inhibitors
etreated with a JNK inhibitor (SP600125, 10 μM), p38 inhibitor
en treated with CAPE (50 μM) for 12 h. Cell extracts were assessed
tibodies. (B) Effect of the anti-p75NTR antagonist on CAPE-induced
antagonist peptide for 1 h and then treated with CAPE for the
sing anti-phospho-p38, anti-phospho-ERK, anti-phospho-JNK,
lized with ECL reagent and quantified by densitometry. The data is
in expression. (C) Effect of MAPK inhibitors on CAPE-inducedp38
tting analysis using antibodies against the phosphorylated forms
Figure 4 Effect of CAPE on the SMase/ceramide pathway.
(A) Time course showing the effect of CAPE on intracellular SMase
activation in C6 glioma cells. Cells were treated with CAPE (50 μM)
for the indicated times, and SMase activation was analyzed using a
fluorometric assay in which SMase activity was directly proportional
to the fluorescence emitted. Data are presented as the mean ± S.D. of
three independent experiments. (B) Time course showing the
effect of CAPE on intracellular ceramide levels in C6 glioma cells.
Cells were treated with CAPE (50 μM) for the indicated times, and
ceramide was resolved by HPTLC. Std, standard (C-2 ceramide). The
ceramide levels are shown as the percentage of the control group
at 0 min. Data are presented as the mean ± S.D. of three independent
experiments. *P < 0.05, compared with 0 min.
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with 50 μM CAPE for 0–24 hr. The cell extracts were
analyzed by immunoblotting with specific antibodies
(anti-CPP32, anti-PARP, anti-NGF, anti-p75, anti-ERKs,
anti-JNKs, anti-p38 MAPK, anti-phosphoserine, anti-
phospho-ERKs (Thr183/Tyr185), anti-phospho-JNKs
(Thr183/Tyr185), and anti-phospho-p38 (Thr180/Tyr182),
as previously described.
DAPI staining
We used DAPI staining to assess morphological changes
in chromatin structure in C6 glioma cells undergoing
apoptosis. Cells were trypsinized, mounted on glass slides,
fixed in 4% paraformaldehyde for 30 min, and stained with
1 μg/ml DAPI for 30 min. Apoptosis was characterized by
chromatin condensation and fragmentation, which were
visualized with fluorescence microscopy.
Statistical analysis
Data were reported as the mean ± SD of three independ-
ent experiments and evaluated by one-way ANOVA. Dif-
ferences were considered significant at P < 0.05.
Results
Involvement of MAPKs in CAPE-mediated caspase 3
activation and PARP cleavage
Consistent with the results of our previous paper, treat-
ment with CAPE (50 μM) for 24 h induced apoptosis [8]
(Figure 1A). In addition, immunoblot analysis with anti-
bodies against the phosphorylated forms of three kinases
showed that CAPE treatment activated ERK, JNK, and
p38 MAPK (Figure 1B). ERK and p38 MAPK were acti-
vated after treatment with CAPE (50 μM) for 0.5 h, and
JNK was activated after treatment for 6 h. The MAPK
signaling inhibitors PD98059, SB203580, and SP600125
blocked CAPE-mediated caspase 3 activation and PARP
cleavage (Figure 1C). Caspase 3 plays an essential role in
executing apoptosis. PARP, an enzyme involved in DNA
repair, genome surveillance, and integrity, is a substrate
of caspase 3. As shown in Figure 1, The MAPK signaling
inhibitors, significantly reversed the CAPE-inhibited
viability at 24 h. These results implied that all three
MAPKs were involved in CAPE-induced apoptotic death
in C6 glioma cells.
Involvement of NGF/p75NTR in CAPE-mediated caspase 3
activation and PARP cleavage
C6 cells were treated with or without 50 μM CAPE for
different lengths of time. NGF increased 2.2-fold, and
p75NTR increased 2.1-fold when compared with protein
levels in control cells. TrkA, another NGF receptor, was
unchanged at 12 h (Figure 2A). To examine whether
the NGF/p75NTR interaction was involved in CAPE-
induced apoptotic death, cells were treated with 50 μMCAPE in the presence or absence of the p75NTR
antagonist peptide (p75 i) for 24 h. The p75NTR an-
tagonist peptide reduced CAPE-mediated caspase 3
activation and PARP cleavage (Figure 2B).
Association of MAPKs and NGF/p75NTR after treatment
with CAPE
Figure 3A shows C6 cells treated with 50 μM CAPE in
the presence or absence of MAPK inhibitors for 12 h.
PD98059, an inhibitor of the MEK/ERK signaling path-
way, reduced NGF and p75NTR expression, but p38
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had no effect. In addition, cells were pretreated with or
without the p75NTR antagonist peptide, and 50 μM CAPE
was then added for the indicated times. Phosphorylation of
JNK was reduced in cells treated with the p75NTR antag-
onist peptide (Figure 3B). The results indicated that ERK
and JNK acted upstream and downstream, respectively, of
NGF/p75NTR. To determine the effect of PD98059 (PD)
or SP600125 (SB) also block CAPE induced p38 activation,
we assessed whole cell lysates from CAPE-treated C6
cells by western blotting analysis. SB203580 (SB) showed
significantly inhibited the CAPE-induced phosphorylation
of p38 but PD98059 (PD) and SP600125 (SP) were not
(Figure 3C).
Activation of N-SMase by CAPE
C6 glioma cells were treated with 50 μM CAPE for
0–180 min. SMase activity was calculated as the percent-
age of fluorescence. Figure 4A shows that N-SMaseFigure 5 Effect of N-SMase on CAPE-induced MAPK activation and NG
of MAPKs by GW4869. C6 glioma cells were pretreated with a sphingom
CAPE (50 μM) for the indicated times. Cell extracts were assessed by we
anti-ERK, anti-phospho-JNK, anti-JNK, and anti-actin antibodies. Bands wer
data is representative of two independent experiments. *, apparent reduc
expression by a sphingomyelinase inhibitor. C6 glioma cells were pretreat
then treated with CAPE (50 μM) for the indicated times. Cell extracts were
anti-actin antibodies.activity peaked at 15 min and then declined within
60 min, whereas A-SMase was only slightly activated by
CAPE. Figure 4B shows the change in ceramide levels.
After CAPE treatment, ceramide increased roughly 3.3-
fold within 15 min and 2-fold within 180 min.
MAPKs and NGF/p75NTR signal downstream of N-SMase
Figure 5A shows that GW4869, an N-SMase inhibitor,
almost blocked the phosphorylation of MAPKs induced
by CAPE. In addition, GW4869 treatment attenuated
the increase in NGF and p75NTR expression induced
by CAPE treatment (Figure 5B). These data identify
MAPKs and NGF/p75NTR as downstream signals in
CAPE-induced N-SMase activation.
CAPE induces apoptosis through N-SMase activation
To confirm that N-SMase activation plays a role in
CAPE-induced apoptosis, cells were treated with 50 μM
CAPE in the presence or absence of GW4869 for 24 h.F/p75NTR expression. (A) Inhibition of CAPE-induced phosphorylation
yelinase inhibitor (GW4869, 20 μM) for 1 h and then treated with
stern blot analysis with anti-phospho-p38, anti-p38, anti-phospho-ERK,
e visualized with ECL reagent and quantified by densitometry. The
tion in expression. (B) Inhibition of CAPE-induced NGF and p75NTR
ed with a sphingomyelinase inhibitor (GW4869, 20 μM) for 1 h and
assessed by western blot analysis with anti-NGF, anti-p75NTR, and
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cleavage in CAPE-treated cells. In addition, the apoptotic
death in C6 cells was analyzed by DAPI staining. Strong
blue fluorescence (indicative of chromatin condensation)
was visible in CAPE-treated apoptotic cells. In contrast,
fluorescence was weak in control cells, cells treated with
GW4869, and cells treated with GW4869 plus CAPE
(Figure 6B). These results indicate that N-SMase plays a
critical role in CAPE-induced apoptosis.
Discussion
Apoptosis, an active process that leads to cell death, is
mediated by programmed signaling pathways that can be
initiated by various extracellular or intracellular stimuli.Figure 6 Critical role of N-SMase in CAPE-induced apoptosis. (A) Inhib
myelinase inhibitor. C6 glioma cells were pretreated with a sphingomyelina
(50 μM) for the indicated times. Cell extracts were assessed by western blo
(B) C6 glioma cells were pretreated with a sphingomyelinase inhibitor (GW
Apoptosis was detected with DAPI staining.The ability to efficiently induce apoptosis is essential for
the development of effective cancer therapies. In the
present study, we demonstrated that CAPE-induced
apoptosis involves the activation of N-SMase and the
accumulation of ceramide. Blocking the activation of
N-SMase decreased CAPE-induced caspase 3 activation
and PARP cleavage. These results demonstrate the
pivotal role of N-SMase in CAPE-induced apoptosis.
SMases are activated in response to several stimuli [25].
In particular, the neutral Mg2+-dependent N-SMase
is regulated by glutathione (GSH) [20]. Moreover, the
reduction in cellular GSH levels induced by TNF-α
signaling activates N-SMase [26]. Consistently, in our
study, GSH was depleted in CAPE-treated C6 gliomaition of CAPE-induced caspase-3 and PARP expression by a sphingo-
se inhibitor (GW4869, 20 μM) for 1 h and then treated with CAPE
t analysis with anti-procaspase-3, anti-PARP, and anti-actin antibodies.
4869, 20 μM) for 1 hand and then treated with CAPE (50 μM) for 24 h.
Tseng et al. Journal of Biomedical Science 2014, 21:61 Page 9 of 11
http://www.jbiomedsci.com/content/21/1/61cells (data not shown), and N-SMase was activated.
However, the mechanism by which CAPE reduces GSH
levels requires further investigation.
p75NTR induces cell death in primary trigeminal,
sympathetic neurons as well as in Schwann and neuro-
blastoma cells. The signaling events that link p75NTR
activation to apoptosis have begun to emerge. p75NTR-
dependent apoptosis is associated with an increase in
JNK activity and caspase activation [27,28]. Consistently,
our results demonstrated that CAPE-induced p75NTR
expression was associated with the activation of JNK and
caspase 3. CAPE increased the expression of p75NTR,
but not TrkA, within 6 h. The rapid increase in p75NTR
might be regulated at the translational or post-translational
level. However, it might also result from a decrease in
p75NTR degradation, which may occur under physio-
logical conditions. On the other hand, the NGF level
also increased after treatment with CAPE. NGF exerts
different effects by binding with its receptors, TrkA
and p75NTR. TrkA transduces NGF signals for sur-
vival and differentiation, whereas p75NTR induces cell
death. The increase in NGF and p75NTR shown in the
present study indicates an amplification of apoptotic
signals.
Our study indicates that the p38 MAPK/p53 activation
and ERK/NGFR/NGF/JUNK pathway are two parallel
pathway to activate caspase 3 and leading to cell death.Figure 7 Schematic presentation of the signaling pathways involved
of CAPE on the MAPKs signaling triggering activation of NGF/p75NTR/JNK
up-regulation and increases an apoptosis cascade.As shown in Figure 3A, the MAPK signaling inhibitor
(PD98059), significantly reversed the CAPE-induced ex-
pression of p75NTR and NGF at 12 h, but p38 MAPK
inhibitor SB203580 and JNK inhibitor SP600125 had
no effect. To determine the effect of SMase inhibitor
(GW4869) also block CAPE induced MAPKs activation,
we assessed whole cell lysates from CAPE-treated C6
cells by western blotting analysis (Figure 5A). GW4869
showed significantly inhibited all the CAPE-induced
phosphorylation of MAPKs. Taken together, our data
contribute new information about the mechanisms by
which CAPE induces the apoptosis of C6 cells. We
found that treatment of C6 cells with CAPE sequen-
tially resulted in the activation of the signaling path-
ways mediated by N-SMase activation. Activation of
the MEK/ERK pathway led to upregulation of NGF/
p75NTR/JNK, whereas activation of the p38 MAPK
pathway was related to an increase in p53 dependent
apoptosis and increases in the activation of caspase 3
and PARP cleavage [8]. We have identified a novel role
of CAPE as an effective therapeutic agent against gli-
oma cells (Figure 7).
Conclusion
Our previous paper demonstrated that CAPE activated
p38 MAPK and that p38 kinase formed a complex with
p53, resulting in the release of cytochrome C afterin CAPE-induced apoptotic pathway in C6 glioma cells. The effect
and p53 dependent apoptosis, which induces the N-SMase/ceramide
Tseng et al. Journal of Biomedical Science 2014, 21:61 Page 10 of 11
http://www.jbiomedsci.com/content/21/1/61treatment with CAPE for 0.5 h. Furthermore, we suggest
that N-SMase/ceramide is the upstream target of p38
MAPK. Increasing the apoptotic potential of cancer cells
through rational manipulation of ceramide levels may
improve the efficacy of chemotherapy agents. Although
CAPE induces apoptosis in C6 glioma cells by activat-
ing multiple signaling pathways (Figure 7), the activa-
tion of N-SMase/ceramide plays an essential role. In
conclusion, the N-SMase/ceramide pathway is an im-
portant target of novel chemotherapy agents for the
treatment of glioma.
Our previous paper demonstrated that CAPE acti-
vated p38 MAPK and that p38 kinase formed a complex
with p53, resulting in the release of cytochrome C after
treatment with CAPE for 0.5 h. Furthermore, we sug-
gest that N-SMase/ceramide is the upstream target of
p38 MAPK. Increasing the apoptotic potential of cancer
cells through rational manipulation of ceramide levels
may improve the efficacy of chemotherapy agents. Al-
though CAPE induces apoptosis in C6 glioma cells by
activating multiple signaling pathways (Figure 7), the
activation of N-SMase/ceramide plays an essential role.
In conclusion, the N-SMase/ceramide pathway is an im-
portant target of novel chemotherapy agents for the
treatment of glioma.
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